George Q Daley Selected Research

George Q Daley Research Topics

Disease

24	Neoplasms (Cancer) 09/2021 - 03/2003
15	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 01/2002
13	Carcinogenesis 01/2022 - 06/2004
9	Leukemia 01/2019 - 04/2003
3	Infections 11/2012 - 01/2002
3	Teratoma (Teratoid Tumor) 08/2011 - 05/2009
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 10/2020 - 01/2017
2	Anemia 10/2020 - 12/2016
2	Neuroblastoma 01/2020 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2004
2	Hematologic Diseases (Blood Diseases) 01/2017 - 01/2004
2	Insulin Resistance 09/2011 - 07/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2010 - 04/2003
1	Hypoxia (Hypoxemia) 01/2022
1	Lung Neoplasms (Lung Cancer) 09/2021
1	Circulating Neoplastic Cells 01/2020
1	Renal Hypertension 11/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2019
1	Starvation 12/2017
1	Leber Congenital Amaurosis 01/2017
1	Carcinoma (Carcinomatosis) 09/2015
1	Liver Diseases (Liver Disease) 08/2014
1	Heart Diseases (Heart Disease) 08/2014
1	Nervous System Diseases (Neurological Disorders) 08/2014
1	Retinal Diseases 08/2014
1	Bone Marrow Failure Disorders 07/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2013
1	VLCAD deficiency 07/2013
1	Stroke (Strokes) 01/2013
1	Vascular Diseases (Vascular Disease) 12/2012
1	Encephalitis (Encephalitis, Rasmussen) 11/2012
1	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2012
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 05/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2012
1	Frontotemporal Dementia (Semantic Dementia) 04/2012
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2012
1	Type 2 Diabetes Mellitus (MODY) 09/2011
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 09/2011
1	Mucopolysaccharidosis I (Hurler Syndrome) 01/2011
1	Fanconi Anemia (Fanconi's Anemia) 01/2011
1	Oncogene Addiction 12/2010
1	Myeloid Leukemia (Leukemia, Myelocytic) 08/2010

Drug/Important Bio-Agent (IBA)

11	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2008
7	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 07/2009
7	Oncogene Proteins (Oncogene Protein)IBA 12/2010 - 01/2002
7	Imatinib Mesylate (Gleevec)FDA Link 09/2007 - 03/2003
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2007
5	Pharmaceutical PreparationsIBA 01/2020 - 03/2003
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 12/2005
4	Phosphotransferases (Kinase)IBA 12/2016 - 03/2003
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2010 - 01/2002
3	Tyrosine Kinase InhibitorsIBA 09/2021 - 09/2007
3	Messenger RNA (mRNA)IBA 09/2021 - 12/2005
3	ChromatinIBA 01/2020 - 12/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2012
3	Small Interfering RNA (siRNA)IBA 09/2015 - 05/2009
3	CytokinesIBA 01/2012 - 02/2004
2	Complement System Proteins (Complement)IBA 11/2019 - 02/2004
2	Glucose (Dextrose)FDA LinkGeneric 09/2011 - 07/2010
2	TransferasesIBA 09/2007 - 04/2003
2	bcr-abl Fusion ProteinsIBA 02/2005 - 03/2003
1	ErbB Receptors (EGF Receptor)IBA 09/2021
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 10/2020
1	Protein Subunits (Protein Subunit)IBA 10/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 10/2020
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 01/2018
1	ZincIBA 01/2018
1	Valine (L-Valine)FDA Link 12/2017
1	CateninsIBA 05/2015
1	Mitochondrial DNA (mtDNA)IBA 07/2013
1	T-Cell Acute Lymphocytic Leukemia Protein 1IBA 01/2013
1	cadherin 5IBA 01/2013
1	Toll-Like Receptor 3IBA 11/2012
1	Histones (Histone)IBA 10/2012
1	Lysine (L-Lysine)FDA Link 10/2012
1	HeterochromatinIBA 10/2012
1	Transcription Factor 3IBA 09/2012
1	NF-kappa B (NF-kB)IBA 05/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012
1	Sirolimus (Rapamycin)FDA Link 09/2011
1	Lovastatin (Mevacor)FDA LinkGeneric 09/2011
1	4-phenylbutyric acid (Buphenyl)FDA Link 09/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2011
1	Retinaldehyde (Retinal)IBA 04/2011
1	Iduronidase (alpha-L-Iduronidase)IBA 01/2011
1	GlycosaminoglycansIBA 01/2011
1	AP 24163IBA 08/2009
1	Calcineurin InhibitorsIBA 06/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2009
1	CalcineurinIBA 06/2009

Therapy/Procedure

13	Therapeutics 09/2021 - 05/2003
4	Transplantation 01/2019 - 04/2002
2	Drug Therapy (Chemotherapy) 12/2010 - 04/2003
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2013
1	Aftercare (After-Treatment) 09/2011
1	Cell Transplantation 01/2011
1	Oral Administration 08/2009